PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
48.62
ESG score below 80% of EYEN's 61.51. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
63.54
Environmental score 1.1-1.2x EYEN's 59.00. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
30.99
Social score below 80% of EYEN's 65.64. Jim Chanos would check for potential social license and litigation risks.
51.34
Governance score 80-90% of EYEN's 59.88. Walter Schloss would scrutinize management accountability and board independence.